璞睿生命科技 offers a Digitalized Clinical Operation Solution (DCOs) that integrates end-to-end electronic source (EMR-to-EDC) data traceability with AI-driven data governance and algorithmic decision support. Its core product automates clinical workflows including subject intelligent screening, automated CRF data entry, risk-based centralized monitoring, and multi-center interactive study orchestration. The company says it has commercialized multiple business lines with notable progress in revenue and contracts and has strategic deployments at more than 30 top-tier (class-III) hospitals while expanding cooperation with 100+ hospitals. The platform applies big data, NLP and medical knowledge graphs to standardize multicenter data and reduce manual transcription errors, improving data quality, compliance and trial efficiency. Future plans include continued R&D collaboration with domestic and international clinical institutions and an international, multi-language version of the E2E platform with overseas market expansion planned for the first half of next year.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Dec 2023